DK0850068T3 - Lipidekstrakt med antiinflammatorisk aktivitet - Google Patents

Lipidekstrakt med antiinflammatorisk aktivitet

Info

Publication number
DK0850068T3
DK0850068T3 DK96929129T DK96929129T DK0850068T3 DK 0850068 T3 DK0850068 T3 DK 0850068T3 DK 96929129 T DK96929129 T DK 96929129T DK 96929129 T DK96929129 T DK 96929129T DK 0850068 T3 DK0850068 T3 DK 0850068T3
Authority
DK
Denmark
Prior art keywords
pct
lipid extract
date
inflammatory activity
sec
Prior art date
Application number
DK96929129T
Other languages
Danish (da)
English (en)
Inventor
Theodore Macrides
Nicolette Kalafatis
Original Assignee
Pharmalink Internat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmalink Internat Ltd filed Critical Pharmalink Internat Ltd
Application granted granted Critical
Publication of DK0850068T3 publication Critical patent/DK0850068T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96929129T 1995-09-11 1996-09-10 Lipidekstrakt med antiinflammatorisk aktivitet DK0850068T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN5311A AUPN531195A0 (en) 1995-09-11 1995-09-11 Lipid extract having anti-inflamatory activity
PCT/AU1996/000564 WO1997009992A1 (en) 1995-09-11 1996-09-10 Lipid extract having anti-inflammatory activity

Publications (1)

Publication Number Publication Date
DK0850068T3 true DK0850068T3 (da) 2005-08-15

Family

ID=3789640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96929129T DK0850068T3 (da) 1995-09-11 1996-09-10 Lipidekstrakt med antiinflammatorisk aktivitet

Country Status (12)

Country Link
US (2) US6083536A (de)
EP (1) EP0850068B1 (de)
JP (1) JP4101876B2 (de)
AT (1) ATE293984T1 (de)
AU (1) AUPN531195A0 (de)
CA (1) CA2231803C (de)
DE (1) DE69634666T2 (de)
DK (1) DK0850068T3 (de)
ES (1) ES2241001T3 (de)
PT (1) PT850068E (de)
WO (1) WO1997009992A1 (de)
ZA (1) ZA967626B (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
AU755476B2 (en) * 1997-06-04 2002-12-12 Cellular Improvements Ltd Method and apparatus for disruption of biological material
SE9703085D0 (sv) * 1997-08-27 1997-08-27 Micro Active Protein In Sweden Anti-microbial composition
US7220427B2 (en) 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
AUPP910699A0 (en) * 1999-03-10 1999-04-01 Pharmalink International Limited Inhibitor of lipoxygenase pathways
AU2005200953B2 (en) * 1999-03-22 2007-07-12 Mars, Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals and method of manufacturing same
US6596303B1 (en) * 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
US20020018787A1 (en) * 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
WO2001005411A1 (en) * 1999-07-21 2001-01-25 Bomac Laboratories Limited Compositions addressing inflammation and/or degenerative disorders
CA2382670A1 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
AUPR030800A0 (en) * 2000-09-22 2000-10-12 Pharmalink International Limited Immunomodulatory preparation
AU9347701A (en) * 2000-09-22 2002-04-02 Pharmalink Internat Ltd Immunomodulatory preparation
US7519546B2 (en) * 2001-04-30 2009-04-14 General Electric Company Maintaining synchronization of information published to multiple subscribers
US8030348B2 (en) 2001-07-27 2011-10-04 Neptune Technologies & Bioressources, Inc. Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
AUPS082102A0 (en) * 2002-03-01 2002-03-21 Women's And Children's Hospital Therapeutic properties of oils
WO2003077811A1 (en) * 2002-03-14 2003-09-25 Mcclung Jackie H Pharmaceutically active compounds containing phosphorous defficient oil
DE20210182U1 (de) * 2002-07-01 2002-10-02 Bio Innovation Dev Ltd Wirkstoffzusammensetzung aus Bestandteilen der Grünlippenmuschel (perna canaliculus) und zusätzlichen Omega-3-Fettsäuren
MXPA05009894A (es) * 2003-03-14 2006-12-14 Foodscience Corp Metodos para el tratamiento de cancer usando componente(s) de perna canaliculus y extractos de perna canaliculus.
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7052715B2 (en) * 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
WO2005073354A1 (en) * 2004-01-30 2005-08-11 Bionovate Limited Solvent extraction of lipids such as essential fatty acids
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
GB0411165D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Hyaluronic acid containing pharmaceutical or veterinary compounds
US20060039992A1 (en) * 2004-06-02 2006-02-23 Miller Bruce A Jr Novel compositions and methods utilizing green-lipped mussel and fatty acids
WO2006052150A1 (en) * 2004-11-15 2006-05-18 University Of Otago Mussel extract composition with enhanced anti-inflammatory activity
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
NZ563125A (en) * 2005-06-03 2009-11-27 Mcfarlane Marketing Aust Pty L Lipid extract of mussels and method for preparation thereof
NZ547429A (en) * 2006-05-24 2009-09-25 Ind Res Ltd Extraction of highly unsaturated lipids with liquid dimethyl ether
WO2008029199A1 (en) 2006-09-03 2008-03-13 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
WO2008044095A1 (en) 2006-10-11 2008-04-17 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
ES2616315T3 (es) 2006-07-18 2017-06-12 Techfields Biochem Co. Ltd Profármacos de ibuprofeno solubles en agua cargados positivamente con una velocidad de penetración en la piel muy rápida
EP2756843A3 (de) 2006-07-25 2014-08-20 Techfields Biochem Co. Ltd Positiv geladene, wasserlösliche Prodrugs von Diclofenac mit sehr schneller Hautpenetrationsrate
HUE028425T2 (en) 2006-08-08 2016-12-28 Techfields Biochem Co Ltd Positive charged water-soluble prodrugs of aryl and heteroarylacetic acids with very fast skin penetration rate
ES2670407T3 (es) 2006-09-03 2018-05-30 Techfields Biochem Co. Ltd Profármacos de acetaminofén solubles en agua cargados positivamente y compuestos relacionados con una tasa de penetración de la piel muy rápida
WO2008035756A1 (fr) * 2006-09-22 2008-03-27 Heimat Co., Ltd. Composition anti-angiogénique comportant un extrait ayant une activité anti-angiogénique et une lécithine
EP2781505A1 (de) * 2006-10-02 2014-09-24 Techfields Biochem Co. Ltd Positiv geladene wasserlöslichen Prodrugs von Prostaglandinen und verwandte Verbindungen mit sehr hohen Hautpenetrierungswerten
NZ552238A (en) * 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
WO2008146298A1 (en) * 2007-06-01 2008-12-04 Ganga Raju Gokaraju Use of aphanamixis polystacha extracts or fractions against 5 -lipoxygenase mediated diseases
RU2509076C2 (ru) 2007-06-04 2014-03-10 Текфилдз Инк Пролекарства нестероидных противовоспалительных средств (nsaia) c очень высокой скоростью проникновения через кожу и мембраны и новые медицинские применения указанных пролекарств
BRPI0822603A2 (pt) * 2008-04-28 2015-06-16 Vermont Italia Srl Formulação farmacêutica contendo palmitoil etanolamina e estearoil etanolamina.
EP2370406A4 (de) 2008-12-04 2014-02-19 Chongxi Yu Zusammensetzungen mit hoher penetration und ihre anwendungen
JP5313064B2 (ja) * 2009-07-03 2013-10-09 株式会社ノエビア 中性脂肪蓄積促進剤、豊胸剤
KR102232625B1 (ko) 2012-05-16 2021-03-25 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
JP6176655B2 (ja) * 2013-07-02 2017-08-09 御木本製薬株式会社 マトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤、老化防止用皮膚外用剤、シワ防止用皮膚外用剤、慢性関節リウマチ及び他の疾患の治療又は予防剤
KR102468519B1 (ko) * 2015-07-20 2022-11-21 장인 벵트 아이. 사무엘손 인스티튜트 오브 라이프 사이언스 컴퍼니 리미티드 피부 염증의 억제에서의 홍합 접착 단백질 제품 및 이의 적용
US11260018B2 (en) 2015-09-17 2022-03-01 Jrx Biotechnology, Inc. Approaches for improving skin hydration and moisturization
AU2017380469A1 (en) * 2016-12-20 2019-06-20 Sanford Limited Bioactive mussel compositions and/or extracts
CN111432654A (zh) * 2017-12-04 2020-07-17 雾凇科技有限公司 从甲壳类捕获物中生产蛋白质磷脂复合物的方法
KR20200102914A (ko) * 2017-12-22 2020-09-01 파르마링크 인터내셔날 리미티드 지질 조합물
WO2021148777A1 (en) * 2020-01-21 2021-07-29 Lintbells Limited Synergistic compositions
CN113041263B (zh) * 2021-03-15 2023-07-25 青岛大学 一种贻贝功能性脂质在制备治疗2型糖尿病产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010061B1 (de) * 1978-09-25 1983-07-13 Stuart John Mc Farlane Einen Mollusken-Extrakt enthaltende pharmazeutische Zusammensetzungen
US4801453A (en) * 1984-05-01 1989-01-31 James M. Broadbent Stabilized mussel extract
AUPM740594A0 (en) 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AU3156595A (en) * 1994-08-11 1996-03-07 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity

Also Published As

Publication number Publication date
ZA967626B (en) 1997-09-03
ES2241001T3 (es) 2005-10-16
US6083536A (en) 2000-07-04
DE69634666D1 (de) 2005-06-02
DE69634666T2 (de) 2006-04-27
JPH11512400A (ja) 1999-10-26
WO1997009992A1 (en) 1997-03-20
US6346278B1 (en) 2002-02-12
ATE293984T1 (de) 2005-05-15
EP0850068A1 (de) 1998-07-01
AUPN531195A0 (en) 1995-10-05
JP4101876B2 (ja) 2008-06-18
EP0850068B1 (de) 2005-04-27
CA2231803C (en) 2004-11-23
CA2231803A1 (en) 1997-03-20
EP0850068A4 (de) 2000-09-13
PT850068E (pt) 2005-08-31

Similar Documents

Publication Publication Date Title
DK0850068T3 (da) Lipidekstrakt med antiinflammatorisk aktivitet
DE69940975D1 (de) Verwendung von glp-1 oder analoge zur behandlung von schlaganfall
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
ES2164916T3 (es) Tratamiento de la esclerosis multiple.
FI970101A0 (fi) Uusi farmaseuttinen valmiste kivun hallintaan
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
PT668763E (pt) Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento
DE3686582D1 (de) Behandlung einer krankheit vom aids-typ.
DE69814394D1 (de) Verwendung von levobupivacain
RU95103436A (ru) Способ замедления прогрессирования атеросклероза коронарных артерий с помощью правастатина
NO971182L (no) Anvendelse av 2,4-diaminopyrimidin-3-oksyd eller et salt derav for behandling av maturasjons- og struktureringsforstyrrelser av kollagen
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
AU3401093A (en) Therapeutic agent for threatened abortion
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ES2110104T3 (es) Procedimiento para la administracion de soluciones de factor de estimulacion de las colonias de granulocitos.
FI961029A0 (fi) Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla
Bellman AIDS practice issues today: interview with Paul Bellman, MD Interview by John S. James
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
ECSP951424A (es) Procedimiento para la administracion de azitromicina
RU94025309A (ru) Средство для лечения больных обменно-алиментарной формой ожирения